fbpx

Logo

COVID-19 News
Navigation

Fidaxomicin May Be Best Choice for C. difficile

By David Douglas (Reuters Health) | on August 7, 2018 | 0 Comment
Latest News

Topics:

Related

Current Issue

ACEP Now: Vol 43 – No 12 – December 2024

Download PDF

Read More

No Responses to “Fidaxomicin May Be Best Choice for C. difficile”

Leave a Reply

Your email address will not be published. Required fields are marked *


*

Wiley
© 2024. All Rights Reserved. ISSN 2333-2603